Flu, RSV, and COVID Peak Together. Is Your Front Desk Ready?

Every fall and winter, flu, RSV, and COVID-19 converge into one combined hospitalization surge that CDC forecasts publicly, updates every two months, and has bounded within 20% of the actual outcome for two seasons running. The practices that get overwhelmed each year usually aren’t the ones facing the worst virus — they’re the ones that wait for the phones to start ringing before deciding how many people should be answering them.

The planning window is open right now, while the season looks quiet

July reads as the off-season. CDC’s most recent weekly influenza surveillance report puts national flu test positivity at 0.6% for the week ending July 4, 2026, with outpatient visits for influenza-like illness at 1.0% and every one of the 54 reporting jurisdictions logging “minimal” activity. Nothing about that week looks like a capacity problem. That is exactly why it is the week capacity decisions actually get made — or quietly don’t.

CDC does not wait for the calendar to say “flu season” before it starts talking about the season. It publishes a full Respiratory Disease Season Outlook in late August, ahead of any meaningful case counts, based on expert elicitation, historical trends, and scenario modeling from its Center for Forecasting and Outbreak Analytics. It then updates that outlook roughly every two months through the winter. That cadence exists because the agency has learned the same thing a front desk eventually learns the hard way: waiting for the data to be obvious means waiting until it’s too late to staff for it.

Flu, RSV, and COVID don’t take turns — they converge, and the mix rotates

A front desk experiences respiratory season as one long stretch of “everyone is calling.” CDC’s surveillance shows that stretch is actually three separate epidemic curves that happen to crest close together — and which virus leads changes from year to year, even while the total hospital burden stays remarkably stable.

The 2025–2026 season is a clean illustration. Per the March 2026 outlook update, COVID-19’s peak hospitalization rate was just 2.0 per 100,000 in the week ending January 3, 2026 — down sharply from 4.2 per 100,000 at the same point last season, and low enough that CDC called it the first season with minimal COVID-19 activity in parts of the country since the virus emerged in 2019–2020. Influenza, by contrast, stayed the dominant driver: CDC’s in-season severity framework classified it “moderate” across all ages as of late February, with an H3N2 subclade K strain accounting for 92% of genetically characterized samples. RSV was still elevated and possibly not done peaking as of March 6 — its hospitalization rate of 3.2 per 100,000 sat close to, but slightly under, last season’s 3.9 per 100,000 peak.

None of that variation showed up as calm at the front desk. It showed up as one combined wave, because that’s how CDC itself tracks it — as a single number.

The peak date moves by weeks, not days — and that’s the part a fixed calendar misses

If a practice’s entire capacity plan is “staff up for flu season, roughly November through February,” CDC’s own three most recent seasons show how much that window can miss. The 2023–2024 combined peak landed in the week ending December 28, 2023. The 2024–2025 peak landed five weeks later, in the week ending February 1, 2025 — per CDC’s outlook evaluation, that season’s influenza component was the first high-severity flu season since 2017–2018, and it alone drove most of the combined burden. The 2025–2026 peak landed in between, the week ending January 3, 2026.

That’s not noise — it’s the normal range. A practice that pre-books extra coverage for “early winter” catches the 2023–2024 pattern and misses the 2024–2025 one by over a month. One that waits until the news cycle says “bad flu season” is, by definition, reacting after the surveillance data that would have told it sooner was already public. CDC’s own framing makes the same point about itself: the agency states plainly that its outlook “is not intended as a prediction or a forecast” of an exact date — it’s a range, refreshed bi-monthly, meant to move a decision-maker’s planning earlier than the headlines would.

CDC already reset the target for 2026–2027 — before this summer even ended

The full 2026–2027 season outlook — the equivalent of the August 2025 document that opened this season — hasn’t been published as of this writing; CDC’s pattern over the last several years puts that release around late August or September, so it isn’t overdue yet. But the machinery preparing for next season is already moving. On March 13, 2026, the FDA’s vaccine advisory committee met and recommended updating all three virus components of the 2026–2027 U.S. flu vaccines, specifically to target the H3N2 subclade K virus that spread widely this past season. That decision was made five months before this season’s outlook will even publish — because the regulatory and manufacturing calendar for a vaccine formulation starts long before the surveillance calendar for a hospital surge does.

The honest reading isn’t “CDC has told us exactly what October 2026 will look like” — it hasn’t, and pretending otherwise would be the same mistake as trusting a fixed calendar window. The honest reading is narrower and still useful: the agency that tracks this converging surge most closely is already acting on next season, and a practice’s own planning cycle can run on the same rhythm — start now, revisit as CDC’s updates land, rather than waiting for a single forecast to arrive fully formed.

What closing the gap looks like without waiting for the peak to prove it

Closing this gap doesn’t mean predicting the unpredictable — nobody, CDC included, claims to know which week in the 2026–2027 season will be worst. It means building the front-line capacity to absorb whichever week it turns out to be, on the same signal-driven cadence CDC itself uses instead of a static one.

Getting from “counting” to “signal-driven” is an operational decision, not a clinical one. It means a first-line phone and messaging channel that stays open when the desk is saturated, books and reschedules against real slots, and routes anything that sounds urgent to a human — without attempting to diagnose on the line. It means treating CDC’s own bi-monthly cadence (August, then roughly every two months through spring) as a standing calendar reminder to re-check staffing assumptions, not a report nobody outside epidemiology reads. And it means measuring abandoned calls and after-hours attempts now, in the quiet week, while a baseline is cheap to collect and nobody’s judgment is clouded by an actual surge.

If your practice is already living through a flu peak this week, this covers the in-season playbook — this piece is about getting ahead of it before it starts. The same underlying math is why weekend call volume quietly drains Monday’s capacity even outside respiratory season, and it’s the reason the United States market page frames capacity, not headcount, as the thing worth scoping first.